Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Prevalence of Huntington's disease gene CAG repeat alleles in sporadic amyotrophic lateral sclerosis patients.

Ramos EM, Keagle P, Gillis T, Lowe P, Mysore JS, Leclerc AL, Ratti A, Ticozzi N, Gellera C, Gusella JF, Silani V, Alonso I, Brown RH Jr, MacDonald ME, Landers JE.

Amyotroph Lateral Scler. 2012 May;13(3):265-9. doi: 10.3109/17482968.2011.653573. Epub 2012 Mar 13.

PMID:
22409360
[PubMed - indexed for MEDLINE]
2.

PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.

Yu Z, Zhu Y, Chen-Plotkin AS, Clay-Falcone D, McCluskey L, Elman L, Kalb RG, Trojanowski JQ, Lee VM, Van Deerlin VM, Gitler AD, Bonini NM.

PLoS One. 2011 Mar 29;6(3):e17951. doi: 10.1371/journal.pone.0017951.

PMID:
21479228
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients.

Lee T, Li YR, Ingre C, Weber M, Grehl T, Gredal O, de Carvalho M, Meyer T, Tysnes OB, Auburger G, Gispert S, Bonini NM, Andersen PM, Gitler AD.

Hum Mol Genet. 2011 May 1;20(9):1697-700. doi: 10.1093/hmg/ddr045. Epub 2011 Feb 3.

PMID:
21292779
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis.

Conforti FL, Spataro R, Sproviero W, Mazzei R, Cavalcanti F, Condino F, Simone IL, Logroscino G, Patitucci A, Magariello A, Muglia M, Rodolico C, Valentino P, Bono F, Colletti T, Monsurrò MR, Gambardella A, La Bella V.

Neurology. 2012 Dec 11;79(24):2315-20. doi: 10.1212/WNL.0b013e318278b618. Epub 2012 Nov 28.

PMID:
23197749
[PubMed - indexed for MEDLINE]
5.

ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis.

Liu X, Lu M, Tang L, Zhang N, Chui D, Fan D.

Neurobiol Aging. 2013 Sep;34(9):2236.e5-8. doi: 10.1016/j.neurobiolaging.2013.04.009. Epub 2013 Apr 28.

PMID:
23635656
[PubMed - indexed for MEDLINE]
6.

ATAXIN2 CAG-repeat length in Italian patients with amyotrophic lateral sclerosis: risk factor or variant phenotype? Implication for genetic testing and counseling.

Gellera C, Ticozzi N, Pensato V, Nanetti L, Castucci A, Castellotti B, Lauria G, Taroni F, Silani V, Mariotti C.

Neurobiol Aging. 2012 Aug;33(8):1847.e15-21. doi: 10.1016/j.neurobiolaging.2012.02.004. Epub 2012 Mar 16.

PMID:
22425256
[PubMed - indexed for MEDLINE]
7.

Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.

Van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PW, Thijs V, Dubois B, Matthijs G, van den Berg LH, Robberecht W.

Neurology. 2011 Jun 14;76(24):2066-72. doi: 10.1212/WNL.0b013e31821f445b. Epub 2011 May 11.

PMID:
21562247
[PubMed - indexed for MEDLINE]
8.

The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect.

Gispert S, Kurz A, Waibel S, Bauer P, Liepelt I, Geisen C, Gitler AD, Becker T, Weber M, Berg D, Andersen PM, Krüger R, Riess O, Ludolph AC, Auburger G.

Neurobiol Dis. 2012 Jan;45(1):356-61. doi: 10.1016/j.nbd.2011.08.021. Epub 2011 Aug 25.

PMID:
21889984
[PubMed - indexed for MEDLINE]
9.

Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis.

Farg MA, Soo KY, Warraich ST, Sundaramoorthy V, Blair IP, Atkin JD.

Hum Mol Genet. 2013 Feb 15;22(4):717-28. doi: 10.1093/hmg/dds479. Epub 2012 Nov 19.

PMID:
23172909
[PubMed - indexed for MEDLINE]
Free Article
10.

Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis.

Daoud H, Belzil V, Martins S, Sabbagh M, Provencher P, Lacomblez L, Meininger V, Camu W, Dupré N, Dion PA, Rouleau GA.

Arch Neurol. 2011 Jun;68(6):739-42. doi: 10.1001/archneurol.2011.111.

PMID:
21670397
[PubMed - indexed for MEDLINE]
11.

Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions.

Hart MP, Brettschneider J, Lee VM, Trojanowski JQ, Gitler AD.

Acta Neuropathol. 2012 Aug;124(2):221-30. doi: 10.1007/s00401-012-0985-5. Epub 2012 Apr 21.

PMID:
22526021
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis.

Bruson A, Sambataro F, Querin G, D'Ascenzo C, Palmieri A, Agostini J, Gaiani A, Angelini C, Galbiati M, Poletti A, Pennuto M, Pegoraro E, Clementi M, Soraru G.

Eur J Neurol. 2012 Oct;19(10):1373-5. doi: 10.1111/j.1468-1331.2011.03646.x. Epub 2012 Jan 10.

PMID:
22233359
[PubMed - indexed for MEDLINE]
13.

ATXN-2 CAG repeat expansions are interrupted in ALS patients.

Corrado L, Mazzini L, Oggioni GD, Luciano B, Godi M, Brusco A, D'Alfonso S.

Hum Genet. 2011 Oct;130(4):575-80. doi: 10.1007/s00439-011-1000-2. Epub 2011 May 3.

PMID:
21537950
[PubMed - indexed for MEDLINE]
14.

Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis.

Lee T, Li YR, Chesi A, Hart MP, Ramos D, Jethava N, Hosangadi D, Epstein J, Hodges B, Bonini NM, Gitler AD.

Neurology. 2011 Jun 14;76(24):2062-5. doi: 10.1212/WNL.0b013e31821f4447. Epub 2011 May 11.

PMID:
21562248
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS.

Bonini NM, Gitler AD.

J Mol Neurosci. 2011 Nov;45(3):676-83. doi: 10.1007/s12031-011-9548-9. Epub 2011 Jun 10. Review.

PMID:
21660502
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population.

Ma M, Yang Y, Shang H, Su D, Zhang H, Ma Y, Liu Y, Tao D, Zhang S.

J Neurol Sci. 2010 Nov 15;298(1-2):57-60. doi: 10.1016/j.jns.2010.08.024.

PMID:
20864123
[PubMed - indexed for MEDLINE]
17.

Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.

Aziz NA, van Belzen MJ, Coops ID, Belfroid RD, Roos RA.

Eur J Med Genet. 2011 Jul-Aug;54(4):e413-8. doi: 10.1016/j.ejmg.2011.04.002. Epub 2011 Apr 23.

PMID:
21540131
[PubMed - indexed for MEDLINE]
18.

Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosis.

Chen Y, Huang R, Yang Y, Chen K, Song W, Pan P, Li J, Shang HF.

Neurobiol Aging. 2011 Oct;32(10):1925.e1-5. doi: 10.1016/j.neurobiolaging.2011.05.015. Epub 2011 Jul 7.

PMID:
21741123
[PubMed - indexed for MEDLINE]
19.

De novo mutations in ataxin-2 gene and ALS risk.

Laffita-Mesa JM, Rodríguez Pupo JM, Moreno Sera R, Vázquez Mojena Y, Kourí V, Laguna-Salvia L, Martínez-Godales M, Valdevila Figueira JA, Bauer PO, Rodríguez-Labrada R, González Zaldívar Y, Paucar M, Svenningsson P, Velázquez Pérez L.

PLoS One. 2013 Aug 6;8(8):e70560. doi: 10.1371/journal.pone.0070560. Print 2013.

PMID:
23936447
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2.

Tazen S, Figueroa K, Kwan JY, Goldman J, Hunt A, Sampson J, Gutmann L, Pulst SM, Mitsumoto H, Kuo SH.

JAMA Neurol. 2013 Oct;70(10):1302-4.

PMID:
23959108
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk